SAB Biotherapeutics, Inc.
New Filing
CIK: 0001833214·Biotechnology·DELAWARE·Filed: Aug 5, 2025
Total Offering
$175,000,000
Amount Sold
$175,000,000
Investors
17
First Sale
Jul 21, 2025
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2020
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Samuel Reich | Related Person |
| Eddie Sullivan | Related Person |
| Katie Ellias | Related Person |
| Scott Giberson | Related Person |
| Christine Hamilton | Related Person |
| David Link | Related Person |
| Erick Lucera | Related Person |
| Andrew Moin | Related Person |
| William Polvino | Related Person |
| Jay Skyler | Related Person |
| Jeffrey Spragens | Related Person |
Company
SEC Filing
0000950123-25-007031
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free